Stellus Capital Investment Corp. 10-Q Summary
Business Context and Reporting Period
Company: Stellus Capital Investment Corp. (SCM)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2017
Business Model: Externally managed, closed-end Business Development Company (BDC) regulated under the Investment Company Act of 1940. The Company invests primarily in debt and related equity of middle-market U.S. companies. It operates a Small Business Investment Company (SBIC) subsidiary to access SBA-guaranteed debentures.
Key Financial Metrics (Six Months Ended June 30, 2017)
| Metric | Value |
|---|---|
| Net Investment Income | $9.08 million ($0.65 per share) |
| Net Increase in Net Assets from Operations | $12.07 million ($0.87 per share) |
| Total Investment Income | $20.26 million |
| Total Operating Expenses | $11.18 million |
| Net Realized Gain (Loss) | ($0.71 million) |
| Net Change in Unrealized Appreciation | $3.69 million |
| Net Assets | $216.45 million |
| Net Asset Value (NAV) Per Share | $13.84 |
| Cash and Cash Equivalents | $6.95 million |
| Total Debt Outstanding | $126.58 million (Notes, Credit Facility, SBA Debentures) |
| Asset Coverage Ratio | 4.38x |
Material Changes vs. Prior Period
- Equity Capital Raise: The Company issued 3,162,500 shares in April 2017, raising gross proceeds of $44.59 million. This significantly increased Net Assets from $170.88 million (Dec 31, 2016) to $216.45 million (June 30, 2017).
- Debt Reduction: The Company aggressively reduced leverage on its Credit Facility, paying down the balance from $115.17 million to $38.42 million. This was funded by the equity raise and investment repayments.
- Portfolio Composition: Total portfolio investments decreased slightly in fair value from $365.63 million to $337.37 million due to repayments exceeding new originations, despite the capital raise. The portfolio now consists of 46 companies (up from 45).
- Income Growth: Net Investment Income increased by 12.9% compared to the six months ended June 30, 2016, driven by portfolio growth and prepayment premiums.
- Unrealized Gains: The Company recorded $3.69 million in unrealized appreciation, a significant improvement over the $0.82 million depreciation recorded in the same period in 2016, attributed to tightening market interest rate spreads.
Outlook, Risks, and Unusual Items
- Subsequent Events: Following the quarter end, the Company invested $22.5 million in a new first lien term loan (Resolute Industrial) and received full repayments on two loans (Atkins Nutritionals and OG Systems) totaling $12.0 million. The Company also contributed an additional $20.5 million to its SBIC subsidiary.
- Dividends: The Company declared monthly dividends of $0.1133 per share for July, August, and September 2017. Distributions for the six months ended June 30, 2017, totaled $0.68 per share.
- Asset Quality: As of June 30, 2017, 70% of the portfolio was rated "Category 2" (performing within expectations). One loan (2.1% of portfolio at cost) was on non-accrual status.
- Risk Factors: The filing highlights risks related to the software sector (10.92% of portfolio), including regulatory concerns and competition. The Company is also subject to interest rate risk, though 69% of debt investments have interest rate floors that mitigate downside risk in a rising rate environment.
- Liquidity: The Company maintains sufficient liquidity to fund unfunded commitments of $2.44 million through cash on hand and available borrowings under its Credit Facility.
Investor Verification Checklist
- Capital Raise Impact: Verify the dilution effect of the 3.16 million shares issued at $14.10/share versus the current market price and NAV.
- Debt Maturity Profile: Confirm the maturity dates of the $25 million Notes (April 2019) and the Credit Facility (October 2018) to assess refinancing needs.
- SBIC Leverage: Review the $65 million SBA debentures and the regulatory capital contribution of $58.5 million (post-subsequent event) to understand leverage capacity.
- Non-Accrual Status: Investigate the specific portfolio company on non-accrual status (2.1% of cost) and the likelihood of recovery.
- Software Sector Exposure: Assess the concentration risk in the software sector (10.92% of portfolio) given the specific risk factors cited in the filing.